Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 31 (NPM1P31)

Target
NPM1P31
Molecular classification
Other (pseudogene; not a protein-coding gene)
01

Overview

Nucleophosmin 1 pseudogene 31 (*NPM1P31*) is a pseudogene and does not code for a functional protein. It is derived from duplication or retrotransposition events involving the NPM1 gene[1][5]. While NPM1 is a well-characterized protein involved in ribosome biogenesis, genomic stability, and is a frequent mutation target in acute myeloid leukemia[1][3][5], its pseudogene NPM1P31 is not known to be biologically active, nor is it classified as a druggable or therapeutic target. No aliases or alternative names are commonly used for this pseudogene, and no data link it to any role in disease or pharmacology. The entry is likely incorrect if meant as a therapeutic target, given the lack of functional protein coding and biological activity. Clarification regarding "is_incorrect": This target is not a recognized therapeutic target—*NPM1P31* (nucleophosmin 1 pseudogene 31) is a pseudogene, not a receptor, enzyme, transporter, or any protein involved in drug development or therapy[1][5]. If the query intended the functional NPM1 protein, the canonical entry should be "Nucleophosmin" (NPM1), not this pseudogene. Thus, this entry is considered incorrect for pharmacological/targeting purposes.

Other names
NPM1 pseudogene 31
02

Mechanism of action

Null (not a drug target)

03

Biological functions

Null (no known functions; pseudogenes generally do not encode functional products)
04

Disease associations

Null (no established disease role for NPM1P31 itself)
05

Safety considerations

Null (no therapeutic use, thus no safety profile)
06

Interacting drugs

Null (no known drug interactions)
07

Biomarkers

Null (no known biomarker role)

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 31 (NPM1P31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 31 (NPM1P31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call